A. 10725 2
Section 1. Paragraph 9 of subsection (a) of section 4902 of the insur-
ance law, as added by chapter 41 of the laws of 2014, is amended to read
as follows:
(9) When conducting utilization review for purposes of determining
health care coverage for substance use disorder treatment, a utilization
review agent shall utilize [recognized] evidence-based and peer reviewed
clinical review [criteria] TOOLS DESIGNATED BY THE OFFICE OF ALCOHOLISM
AND SUBSTANCE ABUSE SERVICES that [is] ARE appropriate to the age of the
patient and [is deemed appropriate and approved for such use by the
commissioner of the office of alcoholism and substance abuse services in
consultation with the commissioner of health and the superintendent.
The office of alcoholism and substance abuse services in consultation
with the commissioner of health and the superintendent shall approve a
recognized evidence-based and peer reviewed clinical review criteria, in
addition to any other approved evidence-based and peer reviewed clinical
review criteria] CONSISTENT WITH THE TREATMENT SERVICE LEVELS WITHIN THE
OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES SYSTEM. ALL APPROVED
TOOLS SHALL HAVE INTER RATER RELIABILITY TESTING COMPLETED BY DECEMBER
THIRTY-FIRST, TWO THOUSAND SIXTEEN.
S 2. Paragraph (i) of subdivision 1 of section 4902 of the public
health law, as added by chapter 41 of the laws of 2014, is amended to
read as follows:
(i) When conducting utilization review for purposes of determining
health care coverage for substance use disorder treatment, a utilization
review agent shall utilize [recognized] evidence-based and peer reviewed
clinical review [criteria] TOOLS DESIGNATED BY THE OFFICE OF ALCOHOLISM
AND SUBSTANCE ABUSE SERVICES that [is] ARE appropriate to the age of the
patient and [is deemed appropriate and approved for such use by the
commissioner of the office of alcoholism and substance abuse services in
consultation with the commissioner and the superintendent of financial
services.
The office of alcoholism and substance abuse services in consultation
with the commissioner and the superintendent of financial services shall
approve a recognized evidence-based and peer reviewed clinical review
criteria, in addition to any other approved evidence-based and peer
reviewed clinical review criteria] CONSISTENT WITH THE TREATMENT SERVICE
LEVELS WITHIN THE OFFICE OF ALCOHOLISM AND SUBSTANCE ABUSE SERVICES
SYSTEM. ALL APPROVED TOOLS SHALL HAVE INTER RATER RELIABILITY TESTING
COMPLETED BY DECEMBER THIRTY-FIRST, TWO THOUSAND SIXTEEN.
S 3. Any utilization review agent utilizing evidence-based and peer
reviewed clinical review criteria approved by the office of alcoholism
and substance abuse services on or before the effective date of this act
shall have until December 31, 2016 to have their review tools redesig-
nated by the office of alcoholism and substance abuse services pursuant
to paragraph 9 of subsection (a) of section 4902 of the insurance law.
S 4. This act shall take effect immediately and shall apply to poli-
cies and contracts issued, renewed, modified, altered or amended on and
after January 1, 2017.
PART B
Section 1. Subsection (i) of section 3216 of the insurance law is
amended by adding a new paragraph 31-a to read as follows:
(31-A) (A) EVERY POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMI-
LAR COMPREHENSIVE-TYPE COVERAGE AND PROVIDES COVERAGE FOR PRESCRIPTION
DRUGS FOR MEDICATION FOR THE TREATMENT OF A SUBSTANCE USE DISORDER SHALL
A. 10725 3
INCLUDE IMMEDIATE ACCESS, WITHOUT PRIOR AUTHORIZATION, TO A FIVE DAY
EMERGENCY SUPPLY OF PRESCRIBED MEDICATIONS COVERED UNDER THE POLICY FOR
THE TREATMENT OF SUBSTANCE USE DISORDER WHERE AN EMERGENCY CONDITION
EXISTS, INCLUDING A PRESCRIBED DRUG OR MEDICATION ASSOCIATED WITH THE
MANAGEMENT OF OPIOID WITHDRAWAL AND/OR STABILIZATION, EXCEPT WHERE
OTHERWISE PROHIBITED BY LAW. FURTHER, COVERAGE OF AN EMERGENCY SUPPLY
SHALL INCLUDE MEDICATION FOR OPIOID OVERDOSE REVERSAL OTHERWISE COVERED
UNDER THE POLICY PRESCRIBED TO AN INDIVIDUAL COVERED BY THE POLICY.
(B) FOR PURPOSES OF THIS PARAGRAPH, AN "EMERGENCY CONDITION" MEANS A
SUBSTANCE USE DISORDER CONDITION THAT MANIFESTS ITSELF BY ACUTE SYMPTOMS
OF SUFFICIENT SEVERITY, INCLUDING SEVERE PAIN OR THE EXPECTATION OF
SEVERE PAIN, SUCH THAT A PRUDENT LAYPERSON, POSSESSING AN AVERAGE KNOW-
LEDGE OF MEDICINE AND HEALTH, COULD REASONABLY EXPECT THE ABSENCE OF
IMMEDIATE MEDICAL ATTENTION TO RESULT IN:
(I) PLACING THE HEALTH OF THE PERSON AFFLICTED WITH SUCH CONDITION IN
SERIOUS JEOPARDY, OR IN THE CASE OF A BEHAVIORAL CONDITION, PLACING THE
HEALTH OF SUCH PERSON OR OTHERS IN SERIOUS JEOPARDY;
(II) SERIOUS IMPAIRMENT TO SUCH PERSON'S BODILY FUNCTIONS;
(III) SERIOUS DYSFUNCTION OF ANY BODILY ORGAN OR PART OF SUCH PERSON;
(IV) SERIOUS DISFIGUREMENT OF SUCH PERSON; OR
(V) A CONDITION DESCRIBED IN CLAUSE (I), (II), OR (III) OF SECTION
1867(E)(1)(A) OF THE SOCIAL SECURITY ACT.
(C) COVERAGE PROVIDED UNDER THIS PARAGRAPH MAY BE SUBJECT TO COPAY-
MENTS, COINSURANCE, AND ANNUAL DEDUCTIBLES THAT ARE CONSISTENT WITH
THOSE IMPOSED ON OTHER BENEFITS WITHIN THE POLICY; PROVIDED, HOWEVER, NO
POLICY SHALL IMPOSE AN ADDITIONAL COPAYMENT OR COINSURANCE ON AN INSURED
WHO RECEIVED AN EMERGENCY SUPPLY OF MEDICATION AND THEN RECEIVED UP TO A
THIRTY DAY SUPPLY OF THE SAME MEDICATION IN THE SAME THIRTY DAY PERIOD
IN WHICH THE EMERGENCY SUPPLY OF MEDICATION WAS DISPENSED. THIS SUBPARA-
GRAPH SHALL NOT PRECLUDE THE IMPOSITION OF A COPAYMENT OR COINSURANCE ON
THE INITIAL EMERGENCY SUPPLY OF MEDICATION IN AN AMOUNT THAT IS LESS
THAN THE COPAYMENT OR COINSURANCE OTHERWISE APPLICABLE TO A THIRTY DAY
SUPPLY OF SUCH MEDICATION, PROVIDED THAT THE TOTAL SUM OF THE COPAYMENTS
OR COINSURANCE FOR AN ENTIRE THIRTY DAY SUPPLY OF THE MEDICATION DOES
NOT EXCEED THE COPAYMENT OR COINSURANCE OTHERWISE APPLICABLE TO A THIRTY
DAY SUPPLY OF SUCH MEDICATION.
S 2. Subsection (l) of section 3221 of the insurance law is amended by
adding two new paragraphs 7-a and 7-b to read as follows:
(7-A) EVERY POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR
COMPREHENSIVE-TYPE LARGE GROUP COVERAGE SHALL PROVIDE COVERAGE FOR MEDI-
CATION FOR THE DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE
USE DISORDER APPROVED BY THE FOOD AND DRUG ADMINISTRATION FOR THE DETOX-
IFICATION OR MAINTENANCE TREATMENT OF SUBSTANCE USE DISORDER.
(7-B) (A) EVERY POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR
COMPREHENSIVE-TYPE COVERAGE AND PROVIDES COVERAGE FOR PRESCRIPTION DRUGS
FOR MEDICATION FOR THE TREATMENT OF A SUBSTANCE USE DISORDER SHALL
INCLUDE IMMEDIATE ACCESS, WITHOUT PRIOR AUTHORIZATION, TO A FIVE DAY
EMERGENCY SUPPLY OF PRESCRIBED MEDICATIONS COVERED UNDER THE POLICY FOR
THE TREATMENT OF SUBSTANCE USE DISORDER WHERE AN EMERGENCY CONDITION
EXISTS, INCLUDING A PRESCRIBED DRUG OR MEDICATION ASSOCIATED WITH THE
MANAGEMENT OF OPIOID WITHDRAWAL AND/OR STABILIZATION, EXCEPT WHERE
OTHERWISE PROHIBITED BY LAW. FURTHER, COVERAGE OF AN EMERGENCY SUPPLY
SHALL INCLUDE MEDICATION FOR OPIOID OVERDOSE REVERSAL OTHERWISE COVERED
UNDER THE POLICY PRESCRIBED TO AN INDIVIDUAL COVERED BY THE POLICY.
(B) FOR PURPOSES OF THIS PARAGRAPH, AN "EMERGENCY CONDITION" MEANS A
SUBSTANCE USE DISORDER CONDITION THAT MANIFESTS ITSELF BY ACUTE SYMPTOMS
A. 10725 4
OF SUFFICIENT SEVERITY, INCLUDING SEVERE PAIN OR THE EXPECTATION OF
SEVERE PAIN, SUCH THAT A PRUDENT LAYPERSON, POSSESSING AN AVERAGE KNOW-
LEDGE OF MEDICINE AND HEALTH, COULD REASONABLY EXPECT THE ABSENCE OF
IMMEDIATE MEDICAL ATTENTION TO RESULT IN:
(I) PLACING THE HEALTH OF THE PERSON AFFLICTED WITH SUCH CONDITION IN
SERIOUS JEOPARDY, OR IN THE CASE OF A BEHAVIORAL CONDITION, PLACING THE
HEALTH OF SUCH PERSON OR OTHERS IN SERIOUS JEOPARDY;
(II) SERIOUS IMPAIRMENT TO SUCH PERSON'S BODILY FUNCTIONS;
(III) SERIOUS DYSFUNCTION OF ANY BODILY ORGAN OR PART OF SUCH PERSON;
(IV) SERIOUS DISFIGUREMENT OF SUCH PERSON; OR
(V) A CONDITION DESCRIBED IN CLAUSE (I), (II), OR (III) OF SECTION
1867(E)(1)(A) OF THE SOCIAL SECURITY ACT.
(C) COVERAGE PROVIDED UNDER THIS PARAGRAPH MAY BE SUBJECT TO COPAY-
MENTS, COINSURANCE, AND ANNUAL DEDUCTIBLES THAT ARE CONSISTENT WITH
THOSE IMPOSED ON OTHER BENEFITS WITHIN THE POLICY; PROVIDED, HOWEVER, NO
POLICY SHALL IMPOSE AN ADDITIONAL COPAYMENT OR COINSURANCE ON AN INSURED
WHO RECEIVED AN EMERGENCY SUPPLY OF MEDICATION AND THEN RECEIVED UP TO A
THIRTY DAY SUPPLY OF THE SAME MEDICATION IN THE SAME THIRTY DAY PERIOD
IN WHICH THE EMERGENCY SUPPLY OF MEDICATION WAS DISPENSED. THIS SUBPARA-
GRAPH SHALL NOT PRECLUDE THE IMPOSITION OF A COPAYMENT OR COINSURANCE ON
THE INITIAL EMERGENCY SUPPLY OF MEDICATION IN AN AMOUNT THAT IS LESS
THAN THE COPAYMENT OR COINSURANCE OTHERWISE APPLICABLE TO A THIRTY DAY
SUPPLY OF SUCH MEDICATION, PROVIDED THAT THE TOTAL SUM OF THE COPAYMENTS
OR COINSURANCE FOR AN ENTIRE THIRTY DAY SUPPLY OF THE MEDICATION DOES
NOT EXCEED THE COPAYMENT OR COINSURANCE OTHERWISE APPLICABLE TO A THIRTY
DAY SUPPLY OF SUCH MEDICATION.
S 3. Section 4303 of the insurance law is amended by adding two new
subsections (l-1) and (l-2) to read as follows:
(L-1) EVERY CONTRACT THAT PROVIDES MEDICAL, MAJOR MEDICAL, OR SIMILAR
COMPREHENSIVE-TYPE LARGE GROUP COVERAGE SHALL PROVIDE COVERAGE FOR MEDI-
CATION FOR THE DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE
USE DISORDER APPROVED BY THE FOOD AND DRUG ADMINISTRATION FOR THE DETOX-
IFICATION OR MAINTENANCE TREATMENT OF SUBSTANCE USE DISORDER.
(L-2) (1) EVERY CONTRACT THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMI-
LAR COMPREHENSIVE-TYPE COVERAGE AND PROVIDES COVERAGE FOR PRESCRIPTION
DRUGS FOR MEDICATION FOR THE TREATMENT OF A SUBSTANCE USE DISORDER SHALL
INCLUDE IMMEDIATE ACCESS, WITHOUT PRIOR AUTHORIZATION, TO A FIVE DAY
EMERGENCY SUPPLY OF PRESCRIBED MEDICATIONS COVERED UNDER THE CONTRACT
FOR THE TREATMENT OF SUBSTANCE USE DISORDER WHERE AN EMERGENCY CONDITION
EXISTS, INCLUDING A PRESCRIBED DRUG OR MEDICATION ASSOCIATED WITH THE
MANAGEMENT OF OPIOID WITHDRAWAL AND/OR STABILIZATION, EXCEPT WHERE
OTHERWISE PROHIBITED BY LAW. FURTHER, COVERAGE OF AN EMERGENCY SUPPLY
SHALL INCLUDE MEDICATION FOR OPIOID OVERDOSE REVERSAL OTHERWISE COVERED
UNDER THE CONTRACT PRESCRIBED TO AN INDIVIDUAL COVERED BY THE CONTRACT.
(2) FOR PURPOSES OF THIS PARAGRAPH, AN "EMERGENCY CONDITION" MEANS A
SUBSTANCE USE DISORDER CONDITION THAT MANIFESTS ITSELF BY ACUTE SYMPTOMS
OF SUFFICIENT SEVERITY, INCLUDING SEVERE PAIN OR THE EXPECTATION OF
SEVERE PAIN, SUCH THAT A PRUDENT LAYPERSON, POSSESSING AN AVERAGE KNOW-
LEDGE OF MEDICINE AND HEALTH, COULD REASONABLY EXPECT THE ABSENCE OF
IMMEDIATE MEDICAL ATTENTION TO RESULT IN:
(I) PLACING THE HEALTH OF THE PERSON AFFLICTED WITH SUCH CONDITION IN
SERIOUS JEOPARDY, OR IN THE CASE OF A BEHAVIORAL CONDITION, PLACING THE
HEALTH OF SUCH PERSON OR OTHERS IN SERIOUS JEOPARDY;
(II) SERIOUS IMPAIRMENT TO SUCH PERSON'S BODILY FUNCTIONS;
(III) SERIOUS DYSFUNCTION OF ANY BODILY ORGAN OR PART OF SUCH PERSON;
(IV) SERIOUS DISFIGUREMENT OF SUCH PERSON; OR
A. 10725 5
(V) A CONDITION DESCRIBED IN CLAUSE (I), (II) OR (III) OF SECTION
1867(E)(1)(A) OF THE SOCIAL SECURITY ACT.
(3) COVERAGE PROVIDED UNDER THIS SUBSECTION MAY BE SUBJECT TO COPAY-
MENTS, COINSURANCE, AND ANNUAL DEDUCTIBLES THAT ARE CONSISTENT WITH
THOSE IMPOSED ON OTHER BENEFITS WITHIN THE CONTRACT; PROVIDED, HOWEVER,
NO CONTRACT SHALL IMPOSE AN ADDITIONAL COPAYMENT OR COINSURANCE ON AN
INSURED WHO RECEIVED AN EMERGENCY SUPPLY OF MEDICATION AND THEN RECEIVED
UP TO A THIRTY DAY SUPPLY OF THE SAME MEDICATION IN THE SAME THIRTY DAY
PERIOD IN WHICH THE EMERGENCY SUPPLY OF MEDICATION WAS DISPENSED. THIS
PARAGRAPH SHALL NOT PRECLUDE THE IMPOSITION OF A COPAYMENT OR COINSU-
RANCE ON THE INITIAL LIMITED SUPPLY OF MEDICATION IN AN AMOUNT THAT IS
LESS THAN THE COPAYMENT OR COINSURANCE OTHERWISE APPLICABLE TO A THIRTY
DAY SUPPLY OF SUCH MEDICATION, PROVIDED THAT THE TOTAL SUM OF THE COPAY-
MENTS OR COINSURANCE FOR AN ENTIRE THIRTY DAY SUPPLY OF THE MEDICATION
DOES NOT EXCEED THE COPAYMENT OR COINSURANCE OTHERWISE APPLICABLE TO A
THIRTY DAY SUPPLY OF SUCH MEDICATION.
S 4. Section 364-j of the social services law is amended by adding a
new subdivision 26-b to read as follows:
26-B. MANAGED CARE PROVIDERS SHALL NOT REQUIRE PRIOR AUTHORIZATION FOR
AN INITIAL OR RENEWAL PRESCRIPTION FOR BUPRENORPHINE OR INJECTABLE
NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF OPIOID
ADDICTION UNLESS THE PRESCRIPTION IS FOR A NON-PREFERRED OR NON-FORMU-
LARY FORM OF THE DRUG OR AS OTHERWISE REQUIRED BY SECTION 1927(K)(6) OF
THE SOCIAL SECURITY ACT.
S 5. Section 273 of the public health law is amended by adding a new
subdivision 10 to read as follows:
10. PRIOR AUTHORIZATION SHALL NOT BE REQUIRED FOR AN INITIAL OR
RENEWAL PRESCRIPTION FOR BUPRENORPHINE OR INJECTABLE NALTREXONE FOR
DETOXIFICATION OR MAINTENANCE TREATMENT OF OPIOID ADDICTION UNLESS THE
PRESCRIPTION IS FOR A NON-PREFERRED OR NON-FORMULARY FORM OF SUCH DRUG
AS OTHERWISE REQUIRED BY SECTION 1927(K)(6) OF THE SOCIAL SECURITY ACT.
S 6. This act shall take effect immediately; provided, sections one,
two, and three of this act shall take effect on the first of January
next succeeding the date on which it shall have become a law and shall
apply to policies and contracts issued, renewed, modified, altered or
amended on and after such date; and provided further that the amendments
to section 364-j of the social services law made by section four of this
act shall not affect the repeal of such section and shall be deemed to
be repealed therewith.
PART C
Section 1. Section 19.18-a of the mental hygiene law, as added by
chapter 32 of the laws of 2014, is amended to read as follows:
S 19.18-a Heroin and opioid addiction wraparound services demonstration
program.
1. The commissioner, in consultation with the department of health
shall develop a heroin and opioid addiction wraparound services demon-
stration program. This program shall provide wraparound services to
adolescent and adult patients during treatment, INCLUDING, BUT NOT
LIMITED TO, INPATIENT AND OUTPATIENT TREATMENT, and shall be available
to such patients for a clinically appropriate period for up to nine
months after completion of such treatment program. The commissioner
shall identify and establish where the wraparound services demonstration
program will be provided.
2. Wraparound services shall include;
A. 10725 6
(a) Case management services which address:
(i) Educational resources;
(ii) Legal services;
(iii) Financial services;
(iv) Social services;
(v) Family services; and
(vi) Childcare services;
(b) Peer supports, including peer to peer support groups;
(c) Employment support; and
(d) Transportation assistance.
3. Not later than [two years after the effective date of this section]
JUNE 30, 2018, the commissioner shall provide the governor, the tempo-
rary president of the senate, the speaker of the assembly, the chair of
the senate standing committee on alcoholism and drug abuse and the chair
of the assembly committee on alcoholism and drug abuse with a written
evaluation of the demonstration program. Such evaluation shall, AT A
MINIMUM, address the overall effectiveness of this demonstration program
[and], IDENTIFY BEST PRACTICES FOR WRAPAROUND SERVICES PROVIDED UNDER
THIS DEMONSTRATION PROGRAM, AND ANY ADDITIONAL WRAPAROUND SERVICES THAT
MAY BE APPROPRIATE WITHIN EACH TYPE OF PROGRAM OPERATED, REGULATED,
FUNDED, OR APPROVED BY THE OFFICE AND ADDRESS whether continuation or
expansion of this demonstration program is recommended. THE WRITTEN
EVALUATION SHALL BE MADE AVAILABLE ON THE OFFICE'S WEBSITE.
S 2. Section 2 of chapter 32 of the laws of 2014, amending the mental
hygiene law relating to the heroin and opioid addiction wraparound
services demonstration program, is amended to read as follows:
S 2. This act shall take effect immediately and shall expire and be
deemed repealed [three years after such effective date] MARCH 31, 2019.
S 3. This act shall take effect immediately; provided, however, that
the amendments to section 19.18-a of the mental hygiene law made by
section one of this act shall not affect the repeal of such section and
shall be deemed repealed therewith.
PART D
Section 1. Section 22.09 of the mental hygiene law, as added by chap-
ter 558 of the laws of 1999, is amended to read as follows:
S 22.09 Emergency services for persons intoxicated, impaired, or inca-
pacitated by alcohol and/or substances.
(a) As used in this article:
1. "Intoxicated or impaired person" means a person whose mental or
physical functioning is substantially impaired as a result of the pres-
ence of alcohol and/or substances in his or her body.
2. "Incapacitated" means that a person, as a result of the use of
alcohol and/or substances, is unconscious or has his or her judgment
otherwise so impaired that he or she is incapable of realizing and
making a rational decision with respect to his or her need for treat-
ment.
3. "Likelihood to result in harm" or "likely to result in harm" means
(i) a substantial risk of physical harm to the person as manifested by
threats of or attempts at suicide or serious bodily harm or other
conduct demonstrating that the person is dangerous to himself or
herself, or (ii) a substantial risk of physical harm to other persons as
manifested by homicidal or other violent behavior by which others are
placed in reasonable fear of serious physical harm.
A. 10725 7
4. ["Hospital" means a general hospital as defined in article twenty-
eight of the public health law] "EMERGENCY SERVICES" MEANS IMMEDIATE
PHYSICAL EXAMINATION, ASSESSMENT, CARE AND TREATMENT OF AN INCAPACITATED
PERSON FOR THE PURPOSE OF CONFIRMING THAT THE PERSON IS, AND CONTINUES
TO BE, INCAPACITATED BY ALCOHOL AND/OR SUBSTANCES TO THE DEGREE THAT
THERE IS A LIKELIHOOD TO RESULT IN HARM TO THE PERSON OR OTHERS.
5. "TREATMENT FACILITY" MEANS A FACILITY DESIGNATED BY THE COMMISSION-
ER WHICH MAY ONLY INCLUDE A GENERAL HOSPITAL AS DEFINED IN ARTICLE TWEN-
TY-EIGHT OF THE PUBLIC HEALTH LAW, OR A MEDICALLY MANAGED OR MEDICALLY
SUPERVISED WITHDRAWAL, INPATIENT REHABILITATION, OR RESIDENTIAL STABILI-
ZATION TREATMENT PROGRAM THAT HAS BEEN CERTIFIED BY THE COMMISSIONER TO
HAVE APPROPRIATE MEDICAL STAFF AVAILABLE ON-SITE AT ALL TIMES TO PROVIDE
EMERGENCY SERVICES AND CONTINUED EVALUATION OF CAPACITY OF INDIVIDUALS
RETAINED UNDER THIS SECTION.
(b) 1. An intoxicated or impaired person may come voluntarily for
emergency [treatment] SERVICES to a chemical dependence program or
treatment facility authorized by the commissioner to [give such emergen-
cy treatment] PROVIDE SUCH EMERGENCY SERVICES. A person who appears to
be intoxicated or impaired and who consents to the proffered help may be
assisted by any peace officer acting pursuant to his or her special
duties, police officer, or by a designee of the director of community
services to return to his or her home, to a chemical dependence program
or treatment facility, or to any other facility authorized by the
commissioner to [give emergency treatment] PROVIDE SUCH EMERGENCY
SERVICES. In such cases, the peace officer, police officer, or designee
of the director of community services shall accompany the intoxicated or
impaired person in a manner which is reasonably designed to assure his
or her safety, as set forth in regulations promulgated in accordance
with subdivision [(f)] (D) of this section.
[(c)] 2. A person who appears to be incapacitated by alcohol and/or
substances to the degree that there is a likelihood to result in harm to
the person or to others may be taken by a peace officer acting pursuant
to his or her special duties, or a police officer who is a member of the
state police or of an authorized police department or force or of a
sheriff's department or by the director of community services or a
person duly designated by him or her to a [general hospital or to any
other place authorized by the commissioner in regulations promulgated in
accordance with subdivision (f) of this section to give emergency treat-
ment, for immediate observation, care, and emergency treatment] TREAT-
MENT FACILITY FOR PURPOSES OF RECEIVING EMERGENCY SERVICES. Every
reasonable effort shall be made to protect the health and safety of such
person, including but not limited to the requirement that the peace
officer, police officer, or director of community services or his or her
designee shall accompany the apparently incapacitated person in a manner
which is reasonably designed to assure his or her safety, as set forth
in regulations promulgated in accordance with subdivision [(f)] (D) of
this section.
[(d)] 3. A person who comes voluntarily or is brought without his or
her objection to any such facility or program in accordance with THIS
subdivision [(c) of this section] shall be given emergency care and
treatment at such place if found suitable therefor by authorized person-
nel, or referred to another suitable facility or treatment program for
care and treatment, or sent to his or her home.
4. THE DIRECTOR OF A TREATMENT FACILITY MAY RECEIVE AS A PATIENT IN
NEED OF EMERGENCY SERVICES ANY PERSON WHO APPEARS TO BE INCAPACITATED AS
DEFINED IN THIS SECTION.
A. 10725 8
[(e)] 5. A person who COMES VOLUNTARILY OR is brought with his or her
objection to [any] A TREATMENT facility [or treatment program in accord-
ance with subdivision (c) of this section] shall be examined as soon as
possible BUT NOT MORE THAN TWELVE HOURS AFTER ARRIVING AT SUCH TREATMENT
FACILITY by an examining physician. If such examining physician deter-
mines that such person is incapacitated by alcohol and/or substances to
the degree that there is a likelihood to result in harm to the person or
others, he or she may be retained [for emergency treatment] TO RECEIVE
EMERGENCY SERVICES AND SHALL BE REGULARLY REEVALUATED TO CONFIRM CONTIN-
UED INCAPACITY BY ALCOHOL AND/OR SUBSTANCES TO THE DEGREE THAT THERE IS
A LIKELIHOOD TO RESULT IN HARM TO THE PERSON OR OTHERS. If the examin-
ing physician determines AT ANY TIME that such person is not incapaci-
tated by alcohol and/or substances to the degree that there is a likeli-
hood to result in harm to the person or others, he or she must be
released. Notwithstanding any other law, in no event may such person be
retained against his or her objection beyond whichever is the shorter of
the following: (i) the time that he or she is no longer incapacitated by
alcohol and/or substances to the degree that there is a likelihood to
result in harm to the person or others or (ii) a period longer than
[forty-eight] SEVENTY-TWO hours.
[1.] 6. Every reasonable effort must be made to obtain the person's
consent to give prompt notification of a person's retention in a facili-
ty or program pursuant to this section to his or her closest relative or
friend, and, if requested by such person, to his or her attorney and
personal physician, in accordance with federal confidentiality regu-
lations.
[2.] 7. A person may not be retained pursuant to this section beyond a
period of [forty-eight] SEVENTY-TWO hours without his or her consent.
Persons suitable therefor may be voluntarily admitted to a chemical
dependence program or facility pursuant to this article.
(C) DISCHARGE PROCEDURES. 1. THE DISCHARGE PROCEDURE PROCESS SHALL
BEGIN AS SOON AS THE PATIENT IS ADMITTED TO THE TREATMENT FACILITY AND
SHALL BE CONSIDERED A PART OF THE TREATMENT PLANNING PROCESS. THE
DISCHARGE PLAN SHALL BE DEVELOPED IN COLLABORATION WITH THE PATIENT AND
ANY SIGNIFICANT OTHER(S) THE PATIENT CHOOSES TO INVOLVE. IF THE PATIENT
IS A MINOR, THE DISCHARGE PLAN MUST ALSO BE DEVELOPED IN CONSULTATION
WITH HIS OR HER PARENT OR GUARDIAN, UNLESS THE MINOR IS BEING TREATED
WITHOUT PARENTAL CONSENT AS AUTHORIZED BY SECTION 22.11 OF THIS CHAPTER.
2. NO PATIENT SHALL BE DISCHARGED WITHOUT A DISCHARGE PLAN WHICH HAS
BEEN COMPLETED AND REVIEWED BY THE MULTI-DISCIPLINARY TEAM PRIOR TO THE
DISCHARGE OF THE PATIENT. THIS REVIEW MAY BE PART OF A REGULAR TREATMENT
PLAN REVIEW. THE PORTION OF THE DISCHARGE PLAN WHICH INCLUDES THE REFER-
RALS FOR CONTINUING CARE SHALL BE GIVEN TO THE PATIENT UPON DISCHARGE.
THIS REQUIREMENT SHALL NOT APPLY TO PATIENTS WHO REFUSE CONTINUING CARE
PLANNING, PROVIDED, HOWEVER, THAT THE TREATMENT FACILITY SHALL MAKE
REASONABLE EFFORTS TO PROVIDE INFORMATION ABOUT THE DANGERS OF LONG TERM
SUBSTANCE USE AS WELL AS INFORMATION RELATED TO TREATMENT INCLUDING, BUT
NOT LIMITED TO, THE OASAS HOPELINE AND THE OASAS BED AVAILABILITY DASH-
BOARD.
3. THE DISCHARGE PLAN SHALL BE DEVELOPED BY THE RESPONSIBLE CLINICAL
STAFF MEMBER, WHO, IN THE DEVELOPMENT OF SUCH PLAN, SHALL CONSIDER THE
PATIENT'S SELF-REPORTED CONFIDENCE IN MAINTAINING ABSTINENCE AND FOLLOW-
ING AN INDIVIDUALIZED RELAPSE PREVENTION PLAN. THE RESPONSIBLE CLINICAL
STAFF MEMBER SHALL ALSO CONSIDER AN ASSESSMENT OF THE PATIENT'S HOME AND
FAMILY ENVIRONMENT, VOCATIONAL/EDUCATIONAL/EMPLOYMENT STATUS, AND THE
PATIENT'S RELATIONSHIPS WITH SIGNIFICANT OTHERS. THE PURPOSE OF THE
A. 10725 9
DISCHARGE PLAN SHALL BE TO ESTABLISH THE LEVEL OF CLINICAL AND SOCIAL
RESOURCES AVAILABLE TO THE PATIENT UPON DISCHARGE FROM THE INPATIENT
SERVICE AND THE NEED FOR THE SERVICES FOR SIGNIFICANT OTHERS. THE
DISCHARGE PLAN SHALL INCLUDE, BUT NOT BE LIMITED TO, THE FOLLOWING:
(I) IDENTIFICATION OF CONTINUING CHEMICAL DEPENDENCE SERVICES INCLUD-
ING MANAGEMENT OF WITHDRAWAL OR CONTINUING STABILIZATION AND ANY OTHER
TREATMENT, REHABILITATION, SELF-HELP AND VOCATIONAL, EDUCATIONAL AND
EMPLOYMENT SERVICES THE PATIENT WILL NEED AFTER DISCHARGE;
(II) IDENTIFICATION OF THE TYPE OF RESIDENCE, IF ANY, THAT THE PATIENT
WILL NEED AFTER DISCHARGE;
(III) IDENTIFICATION OF SPECIFIC PROVIDERS OF THESE NEEDED SERVICES;
AND
(IV) SPECIFIC REFERRALS AND INITIAL APPOINTMENTS FOR THESE NEEDED
SERVICES.
4. A DISCHARGE SUMMARY WHICH INCLUDES THE COURSE AND RESULTS OF CARE
AND TREATMENT MUST BE PREPARED AND INCLUDED IN EACH PATIENT'S CASE
RECORD WITHIN TWENTY DAYS OF DISCHARGE.
[(f)] (D) The commissioner shall promulgate ALL RULES AND regulations,
after consulting with representatives of appropriate law enforcement and
chemical dependence providers of services, establishing procedures for
taking intoxicated or impaired persons and persons apparently incapaci-
tated by alcohol and/or substances to their residences or to appropriate
public or private facilities for emergency [treatment] SERVICES and for
minimizing the role of the police in obtaining treatment of such persons
NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION, INCLUDING BUT NOT
LIMITED TO ESTABLISHING PROCEDURES FOR TRANSPORTING INCAPACITATED
PERSONS TO A TREATMENT FACILITY FOR EMERGENCY SERVICES.
S 2. This act shall take effect on the ninetieth day after it shall
have become law; provided however, that any and all regulations neces-
sary for the implementation of this act shall have been promulgated
prior to such effective date.
S 2. Severability clause. If any clause, sentence, paragraph, subdivi-
sion, section or part of this act shall be adjudged by any court of
competent jurisdiction to be invalid, such judgment shall not affect,
impair, or invalidate the remainder thereof, but shall be confined in
its operation to the clause, sentence, paragraph, subdivision, section
or part thereof directly involved in the controversy in which such judg-
ment shall have been rendered. It is hereby declared to be the intent of
the legislature that this act would have been enacted even if such
invalid provisions had not been included herein.
S 3. This act shall take effect immediately provided, however, that
the applicable effective date of Parts A through D of this act shall be
as specifically set forth in the last section of such Parts.